Navigation Links
Agent Orange Exposure Tied to Prostate Cancer Return
Date:4/23/2009

Study finds vets at higher risk of aggressive recurrence only 8 months after surgery

THURSDAY, April 23 (HealthDay News) -- U.S. male military veterans exposed to the Agent Orange herbicide/defoliant are at increased risk for aggressive recurrence of prostate cancer, a new study finds.

It included 1,495 veterans who'd had surgery to remove cancerous prostates. Of those, the 206 men who'd been exposed to Agent Orange were nearly 50 percent more likely to develop an aggressive recurrence of their cancer, even though their disease seemed relatively non-aggressive at the time of surgery.

The study also found it took only eight months for prostate specific antigen (PSA) levels -- an indicator of cancer aggressiveness -- to double among the Agent Orange-exposed veterans with recurrent cancer, compared to more than 18 months among non-exposed veterans.

The study is published in the May issue of the British Journal of Urology International.

"There is something about the biology of these cancers that are associated with prior Agent Orange exposure that is causing them to be more aggressive. We need to get the word out," study corresponding author Dr. Martha Terris, chief of urology at the Charlie Norwood VA Medical Center in Augusta and professor of urology at the Medical College of Georgia School of Medicine, said in a school news release.

She said doctors treating prostate cancer patients who've been exposed to Agent Orange need to be aware that these patients may require closer monitoring and so-called salvage therapy quickly if their prostate cancer returns.

"Not only are their recurrence rates higher, but their cancers are coming back and growing much faster when they do come back," Terris said.

There's increasing evidence that exposure to Agent Orange, which was used during the Vietnam War, increases the risk for a number of health problems. Agent Orange contained a known carcinogen called dioxin, which is also found in herbicides and pesticides used by U.S. farmers, according to background information in the news release about the study.

More information

The American Cancer Society has more about prostate cancer.



-- Robert Preidt



SOURCE: Medical College of Georgia, news release, April 20, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Targeted agent shows promise in biliary cancer study
2. Experimental agents may prevent radiation-induced leukemia
3. Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business
4. By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies
5. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
6. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
7. Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing
8. Agent for Social Change to Lead Nations Largest Membership Organization
9. Prasco Selected as GSKs Generics Marketing and Distribution Agent
10. Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
11. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Agent Orange Exposure Tied to Prostate Cancer Return
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman ... law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at ... DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group ...
(Date:12/8/2016)... Somerset, N.J. (PRWEB) , ... December 08, 2016 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... The PSCI was set up in 2006 as a non-profit organization to unite ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance ... in Hamilton County, is embarking on a charity drive with the aim of ... homes for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... travel vaccines market to grow at a CAGR of 6.83% during ... and the growth prospects of the global travel vaccines market for ... generated from the sales of various vaccines administered to actively immunize ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
Breaking Medicine Technology: